Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

BioCon

www.biocon.com

20th KM Hosur Road
Electronics City
Bangalore
560 100
India

+91 80 2808 2808

Activities

Manufacturing | Research & Development | Pharmaceutical

Related Companies

  • Romaco Holding GmbH
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Nanoform
  • GEA Pharma and Healthcare
  • Starlab
  • Adare Pharma Solutions
  • Beamex
  • Burkert Fluid Control Systems
  • Envair Technology
  • Biopharma Group
  • Asynt
  • PCI Pharma Services
  • Watson Marlow Fluid Technology Solutions
  • Solvias
  • Labtex
  • Piramal Pharma Solutions
  • LB Bohle

Related Content

Biocon collaborates to commercialise generic formulas in South East Asia
Biocon collaborates to commercialise generic formulas in South East Asia
Biocon appoints new CEO
Biocon appoints new CEO
Biocon biologics facility gets FDA nod
Biocon biologics facility gets FDA nod
Biocon recieves GMP status for Malaysian insulin facility
Biocon recieves GMP status for Malaysian insulin facility
Biocon strikes up MYR 300 million ($68m) contract for insulin with Malaysia
Biocon strikes up MYR 300 million ($68m) contract for insulin with Malaysia
Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing
Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing
Biocon's partnership with Mylan makes significant progress
Biocon's partnership with Mylan makes significant progress
Biocon-Mylan programmes make progress
Biocon-Mylan programmes make progress
India and China set to dominate biosimilars market
India and China set to dominate biosimilars market
Indian domestic pharma market on revival path
Indian domestic pharma market on revival path
Interesting times ahead for Indian generics companies
Interesting times ahead for Indian generics companies
India set to be the battleground for biosimilars
India set to be the battleground for biosimilars
Indian Supreme Court move revokes permission for clinical trials
Indian Supreme Court move revokes permission for clinical trials
Asia and Latin America will drive biosimilars growth in next decade, says Visiongain
Asia and Latin America will drive biosimilars growth in next decade, says Visiongain
Pfizer enters US$350m insulin agreement with Biocon
Pfizer enters US$350m insulin agreement with Biocon
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company